Tissue reconstruction
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Our story
Potential
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Modular approach
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
Integrated platform
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Timeline
Meet our leadership team
Management
Christophe Bancel
Co-Founder,
Chief Executive Officer
Christophe Bancel is Co-founder and CEO of TISSIUM. Prior to founding the company, he has held corporate and strategic leadership positions at UCB and Serono and was Co-founder and Business Development Director at Domain Therapeutics. Christophe holds a MSc in Engineering from Ecole Centrale Paris, a MSc in Molecular Biology from the University of Tokyo, and an MBA from INSEAD.
Maria Pereira
Co-Founder,
Chief Innovation Officer
Maria Pereira leads the Innovation Hub at TISSIUM. She co-invented the technology while a PhD student at Prof. Jeff Karp’s Laboratories. She has been recognized for her research by MIT Tech Review’s “35 Innovators Under 35” in 2014, as well as Forbes in its “30 under 30” selection in Healthcare in 2015. Maria holds a PhD in Bioengineering from the MIT-Portugal program and an MBA from INSEAD.
Romain Attard
Chief Financial Officer
Romain is CFO of Tissium. Prior to joining Tissium, Romain spent 11 years working in Corporate Finance at ODDO BHF. Most recently, he served as Managing Director and head of Public M&A / ECM France. He supported numerous IPOs as well as capital increases, delistings, takeovers and other M&A transactions. Romain holds a MSc in Engineering from Ecole Centrale Lille, a Master in Strategy & Management of International Business from ESSEC Business School and did an exchange program at Thunderbird School of Global Management.
Thomas Chabanis
General Counsel
Thomas is General Counsel at TISSIUM. With over 20 years of experience in the legal and healthcare industries, in the United-States, Europe and Asia, Thomas brings extensive knowledge and leadership. Thomas was a lawyer at SHB in Washington and most recently he served as Head of Legal and Compliance International as well as Head of Enterprise Risk Management at UCB. Thomas holds law degrees from the University Panthéon-Sorbonne and the Washington College of Law and is a graduate of the General Management Program at Harvard Business School. Thomas is licensed to practice law before the courts of New York and Washington D.C.
Chris Crisman
Chief Commercial Officer
Chris is Chief Commercial Officer at TISSIUM. With a proven track record in commercial strategy and business development in the medtech industry, Chris brings extensive experience in driving global commercialization efforts and market adoption strategies for innovative medical technologies. Chris has held multiple positions in large organizations such as Boston Scientific and Edwards Lifesciences. More recently, he served as VP North America Sales of Axogen. Chris holds a BS from University of Southern California and a MBA from University of Virginia Darden School of Business.
Lynne Kelley
Chief Medical Officer
Lynne is in charge of Clinical and Medical affairs at TISSIUM. Lynne has over 30 years of experience in the medical device industry and more particularly in clinical and medical affairs. Throughout her career, she has gained extensive leadership experience, having occupied various positions of Chief Medical Officer and VP of Medical Affairs in large groups such as Boston Scientific, Kimberly Clark, BD and Servier. Lynne holds a medical degree from Dartmouth Medical School and completed a fellowship in vascular surgery at the Massachusetts General Hospital and a fellowship in endovascular surgery at the Hospital Henri Mondor in France. Lynne has been a practicing surgeon for 13 years.
Hunt Henrie
Chief Business Officer
Hunt Henrie joined Tissium in early 2021. He is an experienced financial, strategic and biomedical executive with over 30 years of broad-based global financial, investment banking, private equity and corporate C-Level operating experience in public and private healthcare companies. Before joining Tissium Hunt created Sachuest Partners, a strategic advisory firm focused on building leading MedTech companies
Thierry Darnis
Vice President Global Operations
Thierry Darnis leads the Global Operations at Tissium, (Development & industrialization, Quality, Chemical Characterization and Manufacturing). He has a deep background of more than 30 years as a global leader managing major medical device design and production units at world-class companies such as Medtronic and CR Bard but also at innovative startups. Thierry holds a PhD in Biology and Health, specializing in Biomaterials from the University of Bordeaux II.
Ruth Krestin
Vice President Portfolio Strategy
Ruth Krestin is the VP of Portfolio Strategy at Tissium. Ruth has over 11 years of experience in the pharma industry. After starting her career in strategy consulting at PwC, Ruth most recently spent 6 years at AstraZeneca, holding roles of increasing responsibility in both R&D and commercial, including portfolio management, business insights and competitive intelligence. Ruth holds a MSc in Technology Policy from MIT and a BSc in Life Science from University College Utrecht.
Thierry Proust
Senior Director Human Resources
Thierry Proust joined Tissium early 2023 and is in charge of Human Resources. Thierry has more than 25 years of experience in the Biotech and Pharma industry mainly at Guerbet, Roche and UCB. He led different HR teams at affiliates, manufacturing sites, and Global organizations. Today, he supports the development of TISSIUM HR infrastructure globally, with a focus on recruitment and people development.
